Botanical species · safety record

Marsdenia cundurango

The EFSA Compendium of Botanicals holds 3 constituent measurements for Marsdenia cundurango. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Marsdenia cundurango Rchb.f.

3Constituent measurements
0Safety records
3Cited sources
5Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 5 licensed products naming Marsdenia cundurango as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Aged bark
  • Bark
  • Cortex
  • Stem bark

What the records describe

Constituents measured

  • Alkaloids1
  • Saponins1
  • Sarcostin1

Plant parts

  • Bark3

Preparations

  • Solvent extraction3

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsBarkSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
SaponinsBarkSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
SarcostinBarkSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. HAYASHI, K., MITSUHASHI, H. COMPONENTS OF CORTEX CONDURANGO. Chemical & pharmaceutical bulletin, 1968, vol. 16, no. 12, p. 2522-+.
  2. Hayashi, K., Wada, K., Mitsuhashi, H., Bando, H., Takase, M., Terada, S., Koide, Y., Aiba, T., Narita, T., Mizuno, D. Antitumor Active Glycosides from Condurango Cortex. Chemical and pharmaceutical bulletin, 1980, vol. 28, no. 6, p. 1954-1958. DOI
  3. PAILER, M., GANZINGER, D. ALKALOIDS FROM CORTEX CONDURANGO (MARSDENIA-CUNDURANGO-REICHENB FIL). Monatshefte fur chemie, 1975, vol. 106, no. 1, p. 37-54. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue